Ernexa Therapeutics Inc. Variable Lease, Cost
Ernexa Therapeutics Inc. (ERNA) reported Variable Lease, Cost of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-06
- Ernexa Therapeutics Inc. variable lease, cost for the quarter ending 2026-06-30 was $1.00K, a 85.71% decline year-over-year.
- Ernexa Therapeutics Inc. variable lease, cost for the quarter ending 2026-03-31 was $1.00K, a 83.33% decline year-over-year.
- Ernexa Therapeutics Inc. variable lease, cost for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Ernexa Therapeutics Inc. variable lease, cost for the quarter ending 2025-09-30 was $7.00K, a 96.89% decline year-over-year.
- Ernexa Therapeutics Inc. variable lease, cost for fiscal 2025 was $21.00K, a 97.65% decline from fiscal 2024.
- Ernexa Therapeutics Inc. variable lease, cost for fiscal 2024 was $893.00K, a 556.62% increase from fiscal 2023.
- Ernexa Therapeutics Inc. variable lease, cost for fiscal 2023 was $136.00K, a 9.33% decline from fiscal 2022.
- Ernexa Therapeutics Inc. variable lease, cost for fiscal 2022 was $150.00K, a 689.47% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-06 | $1.00K 10-Q · filed 2026-08-06 | $2.00K derived: sum of 3 quarters · filed 2026-08-06 | $9.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-11 | $1.00K derived: sum of 2 quarters · filed 2026-05-11 | $8.00K derived: sum of 3 quarters · filed 2026-05-11 | $15.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $7.00K derived: sum of 2 quarters · filed 2026-03-13 | $14.00K derived: sum of 3 quarters · filed 2026-08-06 | $21.00K 10-K · filed 2026-03-13 | |||
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-07 | $14.00K derived: sum of 2 quarters · filed 2026-08-06 | $21.00K 10-Q · filed 2025-11-07 | $26.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $7.00K 10-Q · filed 2026-08-06 | $13.00K 10-Q · filed 2026-08-06 | $19.00K derived: sum of 3 quarters · filed 2026-08-06 | $244.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $6.00K 10-Q · filed 2026-05-11 | $12.00K derived: sum of 2 quarters · filed 2026-05-11 | $237.00K derived: sum of 3 quarters · filed 2026-05-11 | $569.00K derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $231.00K derived: sum of 2 quarters · filed 2026-03-13 | $563.00K derived: sum of 3 quarters · filed 2026-03-13 | $893.00K 10-K · filed 2026-03-13 | |||
| 2024-09-30 | $225.00K 10-Q · filed 2025-11-07 | $557.00K derived: sum of 2 quarters · filed 2025-11-07 | $887.00K 10-Q · filed 2025-11-07 | $1.00M derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $332.00K 10-Q · filed 2025-08-13 | $663.00K 10-Q · filed 2025-08-13 | $780.00K derived: sum of 3 quarters · filed 2025-08-13 | $786.00K derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $330.00K 10-Q · filed 2025-05-07 | $448.00K derived: sum of 2 quarters · filed 2025-05-07 | $454.00K derived: sum of 3 quarters · filed 2025-05-07 | $461.00K derived: sum of 4 quarters · filed 2025-05-07 | |||
| 2023-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $124.00K derived: sum of 2 quarters · filed 2025-03-12 | $131.00K derived: sum of 3 quarters · filed 2025-03-12 | $136.00K 10-K · filed 2025-03-12 | |||
| 2023-09-30 | $6.00K 10-Q · filed 2024-11-12 | $13.00K derived: sum of 2 quarters · filed 2024-11-12 | $18.00K 10-Q · filed 2024-11-12 | $55.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $7.00K 10-Q · filed 2024-08-13 | $12.00K 10-Q · filed 2024-08-13 | $49.00K derived: sum of 3 quarters · filed 2024-08-13 | $109.00K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $5.00K 10-Q · filed 2024-05-14 | $42.00K derived: sum of 2 quarters · filed 2024-05-14 | $102.00K derived: sum of 3 quarters · filed 2024-05-14 | $153.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $97.00K derived: sum of 2 quarters · filed 2024-03-14 | $148.00K derived: sum of 3 quarters · filed 2024-03-14 | $150.00K 10-K · filed 2024-03-14 | |||
| 2022-09-30 | $60.00K 10-Q · filed 2023-11-13 | $111.00K derived: sum of 2 quarters · filed 2023-11-13 | $113.00K 10-Q · filed 2023-11-13 | $117.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $51.00K 10-Q · filed 2023-08-11 | $53.00K 10-Q · filed 2023-08-11 | $57.00K derived: sum of 3 quarters · filed 2023-08-11 | $63.00K derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $3.00K 10-Q · filed 2023-05-11 | $6.00K derived: sum of 2 quarters · filed 2023-05-11 | $12.00K derived: sum of 3 quarters · filed 2023-05-11 | $13.00K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $9.00K derived: sum of 2 quarters · filed 2023-03-20 | $10.00K derived: sum of 3 quarters · filed 2023-03-20 | $19.00K 10-K · filed 2023-03-20 | |||
| 2021-09-30 | $6.00K 10-Q · filed 2022-11-14 | $5.63K 10-Q · filed 2021-11-12 | $7.00K derived: sum of 2 quarters · filed 2022-11-14 | $16.00K 10-Q · filed 2022-11-14 | $15.98K 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-11 | $1.35K 10-Q · filed 2021-08-13 | $10.00K 10-Q · filed 2022-08-11 | $10.35K 10-Q · filed 2021-08-13 | |||
| 2021-03-31 | $9.00K 10-Q · filed 2022-07-01 | $9.00K 10-Q · filed 2021-05-17 | |||||
| 2020-12-31 | $21.00K 10-K/A · filed 2022-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |